Your browser doesn't support javascript.
loading
Comparison of efficacy between subcutaneous and intravenous application of moss-aGal in the mouse model of Fabry disease.
Dabrowska-Schlepp, Paulina; Busch, Andreas; Shen, Jin-Song; Cheong, Rachel Y; Madsen, Lone Bruhn; Mascher, Daniel; Schiffmann, Raphael; Schaaf, Andreas.
Affiliation
  • Dabrowska-Schlepp P; Eleva GmbH Freiburg Germany.
  • Busch A; Eleva GmbH Freiburg Germany.
  • Shen JS; Institute of Metabolic Disease, Baylor Scott & White Research Institute Dallas Texas USA.
  • Cheong RY; Scantox Sweden (Previously Timeline Bioresearch AB) Lund Sweden.
  • Madsen LB; Scantox Sweden (Previously Timeline Bioresearch AB) Lund Sweden.
  • Mascher D; pharm-analyt Labor GmbH Baden Austria.
  • Schiffmann R; Institute of Metabolic Disease, Baylor Scott & White Research Institute Dallas Texas USA.
  • Schaaf A; Eleva GmbH Freiburg Germany.
JIMD Rep ; 64(6): 460-467, 2023 Nov.
Article in En | MEDLINE | ID: mdl-37927484
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: JIMD Rep Year: 2023 Document type: Article Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: JIMD Rep Year: 2023 Document type: Article Country of publication: Estados Unidos